A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.
Saved in:
| Title: | A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma. |
|---|---|
| Authors: | Kong LR; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csiklr@nus.edu.sg.; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK. csiklr@nus.edu.sg., Mohamed Salleh NAB; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Ong RW; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Syn NL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Goh RM; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Fhu CW; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Tan DSW; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore, 169610, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.; Genome Institute of Singapore, Agency for Science, Technology & Research (A*STAR), Singapore, 138672, Singapore., Iyer NG; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Office of Clinical Sciences, Duke-NUS Medical School, Singapore, 169857, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Kannan S; Bioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, 138671, Singapore., Verma CS; Bioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, 138671, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, 119228, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, 639798, Singapore., Lim YC; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Soo R; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Ho J; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Huang Y; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Lim JSJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Yan BJ; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Nga ME; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Lim SG; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.; Division of Gastroenterology and Hepatology, National University Health System, Singapore, 119074, Singapore., Koeffler HP; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.; Department of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lee SC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Kappei D; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Hung HT; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. phcgbc@nus.edu.sg.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore. phcgbc@nus.edu.sg.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore. phcgbc@nus.edu.sg. |
| Source: | Nature communications [Nat Commun] 2020 Mar 25; Vol. 11 (1), pp. 1556. Date of Electronic Publication: 2020 Mar 25. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-020-15318-5 |
